Hematology
James Cleary, MD/PHD
Associate Professor of Medicine, Harvard Medical School; Co-Director of Clinical Trials, Center for Gastrointestinal Oncology, Dana-Farber Cancer Institute
James M. Cleary, MD, PhD, is a medical oncologist at the Dana-Farber Cancer Institute in Boston, specializing in gastrointestinal malignancies, including pancreatic cancer, cholangiocarcinoma, hepatobiliary cancers, and pancreatic acinar cell carcinoma. He treats adult patients with advanced gastrointestinal cancers, focusing on those with DNA damage repair (DDR) deficiencies. Dr. Cleary leads phase 1 and phase 2 clinical trials evaluating targeted therapies such as PARP inhibitors like nirapari
23+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (2008)
- Internal Medicine (2006)
Education & Training
- Albert Einstein College of Medicine — MD, PhD
- Rutgers College — Undergraduate
- Dana-Farber Cancer Institute — Fellowship, Medical Oncology
- Massachusetts General Hospital — Residency, Internal Medicine
Peer Recognition
- Dana-Farber Cancer Institute — Awards for excellence in patient care
- Harvard Medical School — Awards for teaching
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
Languages
English
Experience
23+ years in practice